Cargando…
Alterations in gut microbiota and host transcriptome of patients with coronary artery disease
BACKGROUND: Coronary artery disease (CAD) is a widespread heart condition caused by atherosclerosis and influences millions of people worldwide. Early detection of CAD is challenging due to the lack of specific biomarkers. The gut microbiota and host-microbiota interactions have been well documented...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623719/ https://www.ncbi.nlm.nih.gov/pubmed/37924005 http://dx.doi.org/10.1186/s12866-023-03071-w |
_version_ | 1785130793763340288 |
---|---|
author | Chen, Liuying Mou, Xuanting Li, Jingjing Li, Miaofu Ye, Caijie Gao, Xiaofei Liu, Xiaohua Ma, Yunlong Xu, Yizhou Zhong, Yigang |
author_facet | Chen, Liuying Mou, Xuanting Li, Jingjing Li, Miaofu Ye, Caijie Gao, Xiaofei Liu, Xiaohua Ma, Yunlong Xu, Yizhou Zhong, Yigang |
author_sort | Chen, Liuying |
collection | PubMed |
description | BACKGROUND: Coronary artery disease (CAD) is a widespread heart condition caused by atherosclerosis and influences millions of people worldwide. Early detection of CAD is challenging due to the lack of specific biomarkers. The gut microbiota and host-microbiota interactions have been well documented to affect human health. However, investigation that reveals the role of gut microbes in CAD is still limited. This study aims to uncover the synergistic effects of host genes and gut microbes associated with CAD through integrative genomic analyses. RESULTS: Herein, we collected 52 fecal and 50 blood samples from CAD patients and matched controls, and performed amplicon and transcriptomic sequencing on these samples, respectively. By comparing CAD patients with health controls, we found that dysregulated gut microbes were significantly associated with CAD. By leveraging the Random Forest method, we found that combining 20 bacteria and 30 gene biomarkers could distinguish CAD patients from health controls with a high performance (AUC = 0.92). We observed that there existed prominent associations of gut microbes with several clinical indices relevant to heart functions. Integration analysis revealed that CAD-relevant gut microbe genus Fusicatenibacter was associated with expression of CAD-risk genes, such as GBP2, MLKL, and CPR65, which is in line with previous evidence (Tang et al., Nat Rev Cardiol 16:137-154, 2019; Kummen et al., J Am Coll Cardiol 71:1184-1186, 2018). In addition, the upregulation of immune-related pathways in CAD patients were identified to be primarily associated with higher abundance of genus Blautia, Eubacterium, Fusicatenibacter, and Monoglobus. CONCLUSIONS: Our results highlight that dysregulated gut microbes contribute risk to CAD by interacting with host genes. These identified microbes and interacted risk genes may have high potentials as biomarkers for CAD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-023-03071-w. |
format | Online Article Text |
id | pubmed-10623719 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106237192023-11-04 Alterations in gut microbiota and host transcriptome of patients with coronary artery disease Chen, Liuying Mou, Xuanting Li, Jingjing Li, Miaofu Ye, Caijie Gao, Xiaofei Liu, Xiaohua Ma, Yunlong Xu, Yizhou Zhong, Yigang BMC Microbiol Research BACKGROUND: Coronary artery disease (CAD) is a widespread heart condition caused by atherosclerosis and influences millions of people worldwide. Early detection of CAD is challenging due to the lack of specific biomarkers. The gut microbiota and host-microbiota interactions have been well documented to affect human health. However, investigation that reveals the role of gut microbes in CAD is still limited. This study aims to uncover the synergistic effects of host genes and gut microbes associated with CAD through integrative genomic analyses. RESULTS: Herein, we collected 52 fecal and 50 blood samples from CAD patients and matched controls, and performed amplicon and transcriptomic sequencing on these samples, respectively. By comparing CAD patients with health controls, we found that dysregulated gut microbes were significantly associated with CAD. By leveraging the Random Forest method, we found that combining 20 bacteria and 30 gene biomarkers could distinguish CAD patients from health controls with a high performance (AUC = 0.92). We observed that there existed prominent associations of gut microbes with several clinical indices relevant to heart functions. Integration analysis revealed that CAD-relevant gut microbe genus Fusicatenibacter was associated with expression of CAD-risk genes, such as GBP2, MLKL, and CPR65, which is in line with previous evidence (Tang et al., Nat Rev Cardiol 16:137-154, 2019; Kummen et al., J Am Coll Cardiol 71:1184-1186, 2018). In addition, the upregulation of immune-related pathways in CAD patients were identified to be primarily associated with higher abundance of genus Blautia, Eubacterium, Fusicatenibacter, and Monoglobus. CONCLUSIONS: Our results highlight that dysregulated gut microbes contribute risk to CAD by interacting with host genes. These identified microbes and interacted risk genes may have high potentials as biomarkers for CAD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-023-03071-w. BioMed Central 2023-11-03 /pmc/articles/PMC10623719/ /pubmed/37924005 http://dx.doi.org/10.1186/s12866-023-03071-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Chen, Liuying Mou, Xuanting Li, Jingjing Li, Miaofu Ye, Caijie Gao, Xiaofei Liu, Xiaohua Ma, Yunlong Xu, Yizhou Zhong, Yigang Alterations in gut microbiota and host transcriptome of patients with coronary artery disease |
title | Alterations in gut microbiota and host transcriptome of patients with coronary artery disease |
title_full | Alterations in gut microbiota and host transcriptome of patients with coronary artery disease |
title_fullStr | Alterations in gut microbiota and host transcriptome of patients with coronary artery disease |
title_full_unstemmed | Alterations in gut microbiota and host transcriptome of patients with coronary artery disease |
title_short | Alterations in gut microbiota and host transcriptome of patients with coronary artery disease |
title_sort | alterations in gut microbiota and host transcriptome of patients with coronary artery disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623719/ https://www.ncbi.nlm.nih.gov/pubmed/37924005 http://dx.doi.org/10.1186/s12866-023-03071-w |
work_keys_str_mv | AT chenliuying alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease AT mouxuanting alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease AT lijingjing alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease AT limiaofu alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease AT yecaijie alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease AT gaoxiaofei alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease AT liuxiaohua alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease AT mayunlong alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease AT xuyizhou alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease AT zhongyigang alterationsingutmicrobiotaandhosttranscriptomeofpatientswithcoronaryarterydisease |